Literature DB >> 19451348

Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.

Jie Yan1, Martin E Young, Lei Cui, Gary D Lopaschuk, Ronglih Liao, Rong Tian.   

Abstract

BACKGROUND: Shift of myocardial substrate preference has been observed in many chronic diseases such as diabetes and heart failure. This study was undertaken to elucidate the mechanisms underlying the chronic substrate switch in adult hearts and to determine the functional consequences of the switch. METHODS AND
RESULTS: Transgenic mice with cardiac-specific overexpression of the insulin-independent glucose transporter GLUT1 (TG) were used to increase intracellular glucose in cardiac myocytes. A high-fat diet was used to increase the fatty acid supply to the heart. High-fat diet induced a 40% increase in fatty acid oxidation in wild-type hearts, whereas glucose oxidation was decreased to 30% of the control. In contrast, glucose oxidation was >2-fold higher in TG hearts, and the high-fat diet failed to upregulate fatty acid oxidation in these hearts. Glucose induced changes in the expression of multiple metabolic genes, including peroxisome proliferator-activated receptor-alpha (decreased by 51%), 3-oxoacid CoA transferase (decreased by 67%), and acetyl-CoA carboxylase (increased by 4-fold), resulting in a remodeling of the metabolic network to favor a shift of substrate preference toward glucose. Although TG mice on a normal diet maintained normal cardiac energetics and function, the inability to upregulate myocardial fatty acid oxidation in TG mice fed a high-fat diet resulted in increased oxidative stress in the heart, activation of p38 mitogen-activated protein kinase, and contractile dysfunction.
CONCLUSIONS: We have demonstrated that chronic increases in myocardial glucose uptake and oxidation reduce the metabolic flexibility and render the heart susceptible to contractile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451348      PMCID: PMC2765220          DOI: 10.1161/CIRCULATIONAHA.108.832915

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress.

Authors:  Ivan Luptak; Jie Yan; Lei Cui; Mohit Jain; Ronglih Liao; Rong Tian
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

Review 2.  Myocardial substrate metabolism in the normal and failing heart.

Authors:  William C Stanley; Fabio A Recchia; Gary D Lopaschuk
Journal:  Physiol Rev       Date:  2005-07       Impact factor: 37.312

3.  Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet.

Authors:  Isidore C Okere; Margaret P Chandler; Tracy A McElfresh; Julie H Rennison; Theodore A Kung; Brian D Hoit; Paul Ernsberger; Martin E Young; William C Stanley
Journal:  Clin Exp Pharmacol Physiol       Date:  2007 Jan-Feb       Impact factor: 2.557

4.  Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.

Authors:  Ivan Luptak; James A Balschi; Yanqiu Xing; Teresa C Leone; Daniel P Kelly; Rong Tian
Journal:  Circulation       Date:  2005-10-03       Impact factor: 29.690

5.  Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK.

Authors:  Julieta Palomeque; Luciana Sapia; Roger J Hajjar; Alicia Mattiazzi; Martín Vila Petroff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-29       Impact factor: 4.733

6.  Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses.

Authors:  A Clerk; S J Fuller; A Michael; P H Sugden
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

7.  Regulation of energy metabolism of the heart during acute increase in heart work.

Authors:  G W Goodwin; C S Taylor; H Taegtmeyer
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

8.  Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy.

Authors:  Lihong Cheng; Guoliang Ding; Qianhong Qin; Yao Huang; William Lewis; Nu He; Ronald M Evans; Michael D Schneider; Florence A Brako; Yan Xiao; Yuqing E Chen; Qinglin Yang
Journal:  Nat Med       Date:  2004-10-10       Impact factor: 53.440

Review 9.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

10.  Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.

Authors:  Jun Yoshioka; Kenichi Imahashi; Scott A Gabel; William A Chutkow; Aurora A Burds; Joseph Gannon; P Christian Schulze; Catherine MacGillivray; Robert E London; Elizabeth Murphy; Richard T Lee
Journal:  Circ Res       Date:  2007-10-04       Impact factor: 17.367

View more
  90 in total

Review 1.  Energetics and metabolism in the failing heart: important but poorly understood.

Authors:  Aslan T Turer; Craig R Malloy; Christopher B Newgard; Mihai V Podgoreanu
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

Review 2.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

3.  Mitochondrial flash as a novel biomarker of mitochondrial respiration in the heart.

Authors:  Guohua Gong; Xiaoyun Liu; Huiliang Zhang; Shey-Shing Sheu; Wang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

4.  Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.

Authors:  John W Elrod; Renee Wong; Shikha Mishra; Ronald J Vagnozzi; Bhuvana Sakthievel; Sanjeewa A Goonasekera; Jason Karch; Scott Gabel; John Farber; Thomas Force; Joan Heller Brown; Elizabeth Murphy; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

5.  The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heart.

Authors:  Paula-Anahi Arias-Loza; Michael C Kreissl; Susanne Kneitz; Franz R Kaiser; Ina Israel; Kai Hu; Stefan Frantz; Barbara Bayer; Karl-Heinz Fritzemeier; Kenneth S Korach; Theo Pelzer
Journal:  Hypertension       Date:  2012-08-14       Impact factor: 10.190

Review 6.  Will the original glucose transporter isoform please stand up!

Authors:  Anthony Carruthers; Julie DeZutter; Amit Ganguly; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

Review 7.  Standard magnetic resonance-based measurements of the Pi→ATP rate do not index the rate of oxidative phosphorylation in cardiac and skeletal muscles.

Authors:  Arthur H L From; Kamil Ugurbil
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-02       Impact factor: 4.249

Review 8.  Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Authors:  Heinrich Taegtmeyer; Christophe Beauloye; Romain Harmancey; Louis Hue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-04       Impact factor: 4.733

Review 9.  Creating and curing fatty hearts.

Authors:  Raffay S Khan; Konstaninos Drosatos; Ira J Goldberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

10.  Transgenic overexpression of ribonucleotide reductase improves cardiac performance.

Authors:  Sarah G Nowakowski; Stephen C Kolwicz; Frederick Steven Korte; Zhaoxiong Luo; Jacqueline N Robinson-Hamm; Jennifer L Page; Frank Brozovich; Robert S Weiss; Rong Tian; Charles E Murry; Michael Regnier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.